Oracle Health Sciences InForm Cloud Service 6.1 Expands RBM
Oracle Health Sciences announced the availability of Oracle Health Sciences InForm Cloud Service 6.1.
Oracle Health Sciences announced the availability of Oracle Health Sciences InForm Cloud Service 6.1. The latest release of the Oracle Health Sciences InForm data capture and management platform provides trial sponsors and contract research organizations (CROs) supports today’s complex trial protocols and environments with advanced data capture/query management and real-time, actionable visibility into data, as well as standards-based, integrated workflows. This latest release enables trial sponsors and CROs to further increase clinical trial speed, efficiency, and accuracy with new capabilities including:
· Expanded risk-based monitoring capacity that enables source verification at the individual and subject level.
· A single location for defining and managing study administrative data in Oracle Health Sciences Central Designer that streamlines trial workflow and simplifies the design, self-deployment, versioning, and maintenance of clinical studies.
· An advanced modeling environment that streamlines management and validation of in-place, protocol amendments.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
Phase III Trial Data Show Subcutaneous Pembrolizumab as Noninferior to IV Keytruda
March 31st 2025Subcutaneous administration of pembrolizumab with chemotherapy demonstrated a nearly 50% reduction in patient chair and treatment room time while maintaining efficacy and safety endpoints compared to intravenous Keytruda.
Reaching Diverse Patient Populations With Personalized Treatment Methods
January 20th 2025Daejin Abidoye, head of solid tumors, oncology development, AbbVie, discusses a number of topics around diversity in clinical research including industry’s greatest challenges in reaching diverse patient populations, personalized treatment methods, recruitment strategies, and more.
